A detailed history of Putnam Investments LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 1,502,390 shares of DNA stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,502,390
Previous 1,461,569 2.79%
Holding current value
$12.6 Million
Previous $2.65 Million 4.01%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $51,434 - $73,069
40,821 Added 2.79%
1,502,390 $2.54 Million
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $83,121 - $131,135
51,628 Added 3.66%
1,461,569 $2.65 Million
Q2 2023

Aug 14, 2023

SELL
$1.14 - $1.95 $2.04 Million - $3.49 Million
-1,791,758 Reduced 55.96%
1,409,941 $2.62 Million
Q1 2023

May 22, 2023

BUY
$1.2 - $2.19 $831,747 - $1.52 Million
693,123 Added 27.63%
3,201,699 $4.26 Million
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $1.23 Million - $2.66 Million
754,733 Added 43.03%
2,508,576 $4.24 Million
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $779,476 - $3.99 Million
1,067,776 Added 155.64%
1,753,843 $5.47 Million
Q2 2022

Aug 15, 2022

BUY
$2.2 - $4.2 $22,193 - $42,369
10,088 Added 1.49%
686,067 $1.63 Million
Q1 2022

May 16, 2022

SELL
$2.83 - $8.69 $318,258 - $977,268
-112,459 Reduced 14.26%
675,979 $2.72 Million
Q4 2021

Feb 14, 2022

SELL
$8.31 - $14.92 $7.13 Million - $12.8 Million
-858,415 Reduced 52.12%
788,438 $6.55 Million
Q3 2021

Nov 15, 2021

BUY
$9.15 - $13.28 $15.1 Million - $21.9 Million
1,646,853 New
1,646,853 $19.1 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.8B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.